Bradford Flint

Practice Areas

A broad range of life sciences companies and investors turn to Brad Flint for his combination of experience, deep industry knowledge and business-oriented legal guidance. Recognized as a Chambers USA leading lawyer for business, Brad draws on a decade of experience representing both emerging and established companies, as well as institutional investors, to guide clients through the complex array of issues they face, from formation through initial public offering.

Brad co-leads Ropes & Gray’s venture investing and emerging company practice, and is a member of the firm’s M&A, and capital markets and governance practices. He advises on minority equity investments, and also on startup and formation matters, corporate governance, debt and equity financing, mergers and acquisitions, intellectual property licensing, employment and consulting arrangements, commercial agreements, and other general corporate matters. Often serving as general or principal outside counsel to emerging companies, Brad provides both strategic advice and ongoing general corporate counsel, working closely with colleagues across the firm to provide clients with comprehensive business and legal guidance while leading significant transactions on their behalf. Clients consider Brad to be a critical partner in helping them to achieve their business goals.

Brad represents clients from a variety of industries, including biotechnology, pharmaceutical, medical device, software and technology. He has been counsel to some of the world’s leading life sciences companies, including Pfizer, Sarepta Therapeutics and Takeda Pharmaceuticals, among others. He also regularly represents investors in connection with venture capital, growth equity and other minority equity investment transactions.